Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-15

Clinical Trial Update: Study to Assess the Efficacy and Safety of Ibuprofen 50 mg/g Gel Compared to Profenid 25mg/g Gel [Phase 3]

View source ↗

Summary

Phase 3 study comparing ibuprofen 50 mg/g gel with Profenid 25 mg/g gel to assess efficacy and safety in musculoskeletal conditions including muscular atrophy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen 50 mg/g Gel (ibuprofen)
  • Profenid 25 mg/g Gel (ketoprofen)

Snippet

Sponsor: Laboratório Teuto Brasileiro S/A | Conditions: Muscular Atrophy, Sprains | Phase 3 | Status: UNKNOWN